Axa S.A. Nevro Corp Transaction History

Axa S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $229,509 - $311,220	-6,300 Closed	0 $0
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $256,157 - $334,089	6,300 New	6,300 $293,000
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $3.09 Million - $3.94 Million	-27,100 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $1.26 Million - $1.83 Million	-14,100 Reduced 34.22%	27,100 $3.24 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $779,553 - $1.6 Million	-11,100 Reduced 21.22%	41,200 $4.12 Million
Q4 2019 Feb 18, 2020	BUY	$76.41 - $117.54 $4 Million - $6.15 Million	52,300 New	52,300 $6.15 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.